U.S. drugmaker Eli Lilly and Co. said it was "deeply concerned" about allegations published in a Chinese newspaper that it spent more than $4.9 million to bribe doctors in China to prescribe the firm's medicines instead of rival products.
Lilly says deeply concerned by bribery allegations in China
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.